Marshall Wace, LLP Third Harmonic Bio, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 22,198 shares of THRD stock, worth $279,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,198

Holding current value

$279,916

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$8.74 - $15.54 $194,010 - $344,956	22,198 New	22,198 $288,000
Q3 2022 Nov 14, 2022	BUY	$16.75 - $19.93 $979,288 - $1.17 Million	58,465 New	58,465 $1.11 Million

Others Institutions Holding THRD

# of Institutions

Shares Held

40.2M

Call Options Held

9.1K

Put Options Held

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$138 Million
18.89% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$72.9 Million
1.81% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$55.1 Million
1.74% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$40.1 Million
1.46% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$37.3 Million
1.22% of portfolio

View Full List

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $509M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account